{"id":"https://openalex.org/W1947252151","doi":null,"title":"Improved circulating half-life and efficacy of an antibody-interleukin 2 immunocytokine based on reduced intracellular proteolysis.","display_name":"Improved circulating half-life and efficacy of an antibody-interleukin 2 immunocytokine based on reduced intracellular proteolysis.","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W1947252151","mag":"1947252151","pmid":"https://pubmed.ncbi.nlm.nih.gov/11801561"},"language":"en","primary_location":{"id":"pmid:11801561","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11801561","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000263428","display_name":"Stephen D. Gillies","orcid":"https://orcid.org/0000-0002-2080-4220","observed_orcids":["https://orcid.org/0000-0002-2080-4220"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen D Gillies","raw_affiliation_strings":["Lexigen Pharmaceuticals Corp., Lexington, Massachusetts 02421-3125, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lexigen Pharmaceuticals Corp., Lexington, Massachusetts 02421-3125, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063573015","display_name":"Kin-Ming Lo","orcid":"https://orcid.org/0000-0002-1178-9954","observed_orcids":["https://orcid.org/0000-0002-1178-9954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kin-Ming Lo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046478195","display_name":"Christa Burger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christa Burger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100306850","display_name":"Lan Yan","orcid":"https://orcid.org/0000-0001-6452-9649","observed_orcids":["https://orcid.org/0000-0001-6452-9649","https://orcid.org/0009-0003-1671-7735","https://orcid.org/0009-0005-9702-2306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Lan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005350858","display_name":"Thomas A. Dahl","orcid":"https://orcid.org/0000-0003-4642-4346","observed_orcids":["https://orcid.org/0000-0003-4642-4346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Dahl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5047602567","display_name":"Wai-Keung Wong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wai-Keung Wong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2649,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.77502246,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"8","issue":"1","first_page":"210","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunocytokines","display_name":"immunocytokines","score":0.8740000128746033},{"id":"https://openalex.org/keywords/circulating-half-life","display_name":"serum half-life","score":0.949999988079071},{"id":"https://openalex.org/keywords/intracellular-proteolysis","display_name":"intracellular proteolysis","score":0.8899999856948853},{"id":"https://openalex.org/keywords/fc-receptor-binding","display_name":"Fc receptor binding","score":0.6679999828338623},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8090000152587891},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9610000252723694},{"id":"https://openalex.org/keywords/fc-gamma-receptor","display_name":"Fc gamma receptor","score":0.6909999847412109},{"id":"https://openalex.org/keywords/effector-function","display_name":"effector function","score":0.621999979019165},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.8069999814033508},{"id":"https://openalex.org/keywords/epithelial-cancers","display_name":"epithelial cancers","score":0.8999999761581421}],"concepts":[{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.6142227053642273},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.6083064079284668},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6075280904769897},{"id":"https://openalex.org/C182220744","wikidata":"https://www.wikidata.org/wiki/Q7251226","display_name":"Proteases","level":3,"score":0.5767773389816284},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.49368342757225037},{"id":"https://openalex.org/C2781307694","wikidata":"https://www.wikidata.org/wiki/Q33123","display_name":"Proteolysis","level":3,"score":0.4841945469379425},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.41989558935165405},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.4142051935195923},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4087461829185486},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3954031765460968},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.388577938079834},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3034204840660095},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.24596267938613892},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1729733645915985},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.07546418905258179},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002403","descriptor_name":"Cathepsins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003546","descriptor_name":"Cysteine Endopeptidases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016297","descriptor_name":"Mutagenesis, Site-Directed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056668","descriptor_name":"Cathepsin L","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11801561","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11801561","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"mag:1947252151","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11801561","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1505676752","https://openalex.org/W1527014890","https://openalex.org/W1794218190","https://openalex.org/W1976624725","https://openalex.org/W2025012298","https://openalex.org/W2036031859","https://openalex.org/W2099962054","https://openalex.org/W2118326757","https://openalex.org/W2122042627","https://openalex.org/W2138985980","https://openalex.org/W2141612652","https://openalex.org/W2144031403","https://openalex.org/W2146457529"],"related_works":["https://openalex.org/W1527014890","https://openalex.org/W1972924063","https://openalex.org/W2133380107","https://openalex.org/W2547940099","https://openalex.org/W4392816973","https://openalex.org/W2022565486","https://openalex.org/W2002540493","https://openalex.org/W4385686413","https://openalex.org/W2049961431","https://openalex.org/W4401420412"],"abstract_inverted_index":{"PURPOSE:":[0],"Previous":[1],"studies":[2],"showed":[3],"that":[4,31,129],"reducing":[5],"the":[6,37,79,83,110,132],"interaction":[7],"of":[8,101,135,157,162,181],"antibody-interleukin":[9],"2":[10],"immunocytokines":[11,48,136,165],"with":[12,117,166],"Fc":[13,41,102,111],"receptors":[14,108],"improved":[15,164],"their":[16,23],"circulating":[17,92,133],"half-life":[18,34,93,134],"in":[19,51,60,67,78,119,154],"mice":[20],"and":[21,56,59,64,85,94,144,155,171],"increased":[22,139],"antitumor":[24,65,95],"activity.":[25,96],"We":[26,125],"sought":[27],"to":[28,39,105,121,141,177],"modify":[29],"sequences":[30],"would":[32],"increase":[33],"but":[35,114],"retain":[36],"ability":[38],"activate":[40],"receptor-mediated":[42],"effector":[43,54,173],"functions.":[44],"EXPERIMENTAL":[45],"DESIGN:":[46],"Modified":[47],"were":[49],"assessed":[50],"vitro":[52],"for":[53,62],"function":[55],"protease":[57],"sensitivity":[58],"vivo":[61],"pharmacokinetic":[63,169],"activities":[66],"an":[68,158],"syngeneic":[69],"tumor":[70],"regression":[71],"model.":[72],"RESULTS:":[73],"Single":[74],"amino":[75],"acid":[76],"changes":[77,118],"junction":[80],"sequence":[81],"between":[82],"antibody":[84],"interleukin-2":[86],"components":[87],"had":[88],"dramatic":[89],"effects":[90],"on":[91,138],"This":[97],"effect":[98],"was":[99,115],"independent":[100],"receptor":[103],"binding":[104],"either":[106],"Fcgamma":[107],"or":[109],"protection":[112],"receptor,":[113],"associated":[116],"susceptibility":[120],"intracellular":[122,142,159],"proteases.":[123],"CONCLUSIONS:":[124],"have":[126,146],"identified":[127],"modifications":[128],"dramatically":[130],"improve":[131],"based":[137],"resistance":[140],"degradation":[143],"thus":[145],"demonstrated":[147],"how":[148],"these":[149,163],"molecules":[150],"can":[151],"be":[152],"recycled":[153],"out":[156],"compartment.":[160],"Use":[161],"highly":[167],"favorable":[168],"properties":[170],"retained":[172],"functions":[174],"should":[175],"lead":[176],"more":[178],"effective":[179],"treatment":[180],"epithelial":[182],"cancers.":[183]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}